Imugene Total Liab vs Total Stockholder Equity Analysis

IMU Stock   0.04  0  2.78%   
Imugene financial indicator trend analysis is infinitely more than just investigating Imugene recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Imugene is a good investment. Please check the relationship between Imugene Total Liab and its Total Stockholder Equity accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Liab vs Total Stockholder Equity

Total Liab vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Imugene Total Liab account and Total Stockholder Equity. At this time, the significance of the direction appears to have strong relationship.
The correlation between Imugene's Total Liab and Total Stockholder Equity is 0.7. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Imugene, assuming nothing else is changed. The correlation between historical values of Imugene's Total Liab and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Imugene are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Total Liab i.e., Imugene's Total Liab and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.7
Relationship DirectionPositive 
Relationship StrengthSignificant

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Imugene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Imugene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to gain to about 54.4 M in 2025, whereas Issuance Of Capital Stock is likely to drop slightly above 57.5 M in 2025.
 2022 2023 2024 2025 (projected)
Reconciled Depreciation190.3K3.3M3.8M4.0M
Net Interest Income1.9M4.0M4.6M4.9M

Imugene fundamental ratios Correlations

0.250.750.790.990.890.98-0.96-0.880.880.990.920.660.990.980.90.940.76-0.970.790.890.990.780.910.96-0.77
0.250.650.630.160.510.31-0.13-0.550.550.230.16-0.210.240.330.140.350.49-0.340.620.520.270.630.110.47-0.01
0.750.651.00.660.940.83-0.56-0.950.930.670.780.490.680.80.690.820.94-0.771.00.940.721.00.730.9-0.48
0.790.631.00.70.960.86-0.61-0.960.950.710.80.510.720.840.720.850.94-0.81.00.960.761.00.760.92-0.52
0.990.160.660.70.830.95-0.98-0.820.810.990.890.660.990.960.880.910.68-0.950.70.820.990.690.890.91-0.78
0.890.510.940.960.830.94-0.77-0.980.980.840.880.60.840.940.810.920.9-0.90.961.00.870.950.850.97-0.66
0.980.310.830.860.950.94-0.9-0.930.920.950.930.720.950.980.870.930.82-0.950.860.940.970.860.910.98-0.7
-0.96-0.13-0.56-0.61-0.98-0.77-0.90.76-0.74-0.98-0.79-0.61-0.98-0.9-0.8-0.84-0.560.94-0.61-0.76-0.97-0.6-0.79-0.860.73
-0.88-0.55-0.95-0.96-0.82-0.98-0.930.76-0.95-0.83-0.85-0.56-0.84-0.91-0.79-0.9-0.90.91-0.96-0.99-0.86-0.96-0.82-0.970.63
0.880.550.930.950.810.980.92-0.74-0.950.830.850.550.830.930.80.90.88-0.890.950.970.860.950.810.96-0.64
0.990.230.670.710.990.840.95-0.98-0.830.830.840.621.00.950.840.890.66-0.960.710.831.00.710.840.93-0.72
0.920.160.780.80.890.880.93-0.79-0.850.850.840.70.850.930.960.940.88-0.840.820.870.860.791.00.9-0.82
0.66-0.210.490.510.660.60.72-0.61-0.560.550.620.70.630.630.590.540.51-0.640.510.60.630.520.70.6-0.44
0.990.240.680.720.990.840.95-0.98-0.840.831.00.850.630.950.840.890.67-0.970.720.841.00.710.840.93-0.72
0.980.330.80.840.960.940.98-0.9-0.910.930.950.930.630.950.920.970.81-0.940.840.930.960.830.920.97-0.8
0.90.140.690.720.880.810.87-0.8-0.790.80.840.960.590.840.920.960.83-0.80.740.80.850.70.970.85-0.93
0.940.350.820.850.910.920.93-0.84-0.90.90.890.940.540.890.970.960.88-0.880.860.910.910.830.930.95-0.86
0.760.490.940.940.680.90.82-0.56-0.90.880.660.880.510.670.810.830.88-0.730.950.90.710.930.860.87-0.64
-0.97-0.34-0.77-0.8-0.95-0.9-0.950.940.91-0.89-0.96-0.84-0.64-0.97-0.94-0.8-0.88-0.73-0.8-0.9-0.97-0.8-0.82-0.950.66
0.790.621.01.00.70.960.86-0.61-0.960.950.710.820.510.720.840.740.860.95-0.80.960.761.00.770.92-0.54
0.890.520.940.960.821.00.94-0.76-0.990.970.830.870.60.840.930.80.910.9-0.90.960.860.960.840.97-0.64
0.990.270.720.760.990.870.97-0.97-0.860.861.00.860.631.00.960.850.910.71-0.970.760.860.750.850.95-0.73
0.780.631.01.00.690.950.86-0.6-0.960.950.710.790.520.710.830.70.830.93-0.81.00.960.750.740.92-0.5
0.910.110.730.760.890.850.91-0.79-0.820.810.841.00.70.840.920.970.930.86-0.820.770.840.850.740.87-0.83
0.960.470.90.920.910.970.98-0.86-0.970.960.930.90.60.930.970.850.950.87-0.950.920.970.950.920.87-0.69
-0.77-0.01-0.48-0.52-0.78-0.66-0.70.730.63-0.64-0.72-0.82-0.44-0.72-0.8-0.93-0.86-0.640.66-0.54-0.64-0.73-0.5-0.83-0.69
Click cells to compare fundamentals

Imugene Account Relationship Matchups

Imugene fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets71.8M147.6M197.1M151.4M174.1M182.8M
Short Long Term Debt Total271.0K673.4K553.5K1.5M1.8M1.9M
Other Current Liab3.6M2.7M3.6M22.4M25.8M27.1M
Total Current Liabilities4.5M7.4M6.1M29.3M33.7M35.4M
Total Stockholder Equity65.0M138.7M189.6M118.3M136.0M142.8M
Property Plant And Equipment Net466.0K862.8K683.0K1.7M1.5M1.6M
Current Deferred Revenue390.6K738.3K1.3M1.6M1.9M2.0M
Net Debt(29.2M)(99.2M)(152.6M)(91.6M)(82.4M)(78.3M)
Retained Earnings(65.7M)(103.5M)(141.4M)(289.8M)(260.8M)(247.8M)
Accounts Payable759.7K4.5M2.3M6.0M6.9M7.2M
Cash29.5M99.9M153.2M93.1M107.1M112.4M
Non Current Assets Total35.5M33.8M31.4M38.4M44.1M46.3M
Cash And Short Term Investments29.5M99.9M153.2M94.5M108.7M114.2M
Net Receivables6.7M12.8M12.1M12.6M14.5M15.2M
Common Stock Shares Outstanding4.7B5.6B6.3B7.1B8.2B8.6B
Liabilities And Stockholders Equity71.8M147.6M197.1M151.4M174.1M182.8M
Non Current Liabilities Total2.3M1.5M1.4M3.8M4.4M4.6M
Other Stockholder Equity(45.5M)(1.0)(127.3M)(173.0M)(155.7M)(147.9M)
Total Liab6.8M8.9M7.4M33.1M38.1M40.0M
Property Plant And Equipment Gross718.9K1.3M1.0M2.6M2.4M2.5M
Total Current Assets36.3M113.8M165.7M113.0M130.0M136.5M
Accumulated Other Comprehensive Income17.6M11.4M16.7M37.8M43.4M45.6M
Short Term Debt106.0K184.2K191.1K912.5K1.0M1.1M
Intangible Assets34.9M32.7M30.5M34.1M39.2M41.2M
Common Stock113.1M230.8M314.4M370.3M425.9M447.2M
Other Liab2.5M2.2M987.1K990.6K1.1M1.1M
Net Tangible Assets29.3M30.1M106.0M159.1M183.0M192.2M
Long Term Investments115.2K252.4K217.6K2.4M2.8M2.9M
Property Plant Equipment155.6K466.0K862.8K683.0K614.7K645.4K
Other Current Assets170.1K1.1M401.6K5.9M6.8M7.1M
Long Term Debt Total8.4K165.0K489.3K362.4K326.2K462.4K
Net Invested Capital65.0M138.7M188.4M118.3M136.0M85.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Imugene Stock Analysis

When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.